It's not just the mitral valve -abnormal motion of the whole aorto-mitral apparatus occurs in both overt and subclinical hypertrophic cardiomyopathy G+LVH-) . However, the geometry of the mitral valve, the subvalvular apparatus and the LVOT is more complex. The purpose of this study was analyse the whole aorto-mitral area (the aorto-mitral apparatus) and track its dynamic motion to explore mechanisms involved in LVOTO-predisposition in subclinical HCM.
Methods
CMR using a 1.5-tesla scanner (Avanto, Siemens) was performed on 35 G+LVH-patients without left atrial (LA) enlargement (31 ± 14 years, 34% male), 31 patients with a clinical diagnosis of HCM with preserved ejection fraction (47 ± 12 years, 61% male, all with pathogenic/ likely pathogenic sarcomere mutations [G+LVH+]), and 53 matched healthy volunteers (45% male, 42 ± 14). Direct assessment of the aortomitral apparatus was performed on the 3-chamber view acquired using a breathheld steady-state free precession sequence. Cines were interrogated frame-by-frame, semi-automatically using an in-house script developed for MATLAB ® . The motion tracking software interactively assigned, tracked and graphed, the dynamic excursion of 4 pre-defined aortomitral regions of interest (ROI) throughout one cardiac cycle: ROI 1 -hinge point of the posterior MVL; ROI 2 -intertrigonal mitral annulus; ROI 3 -tip of the AMVL; ROI 4 -anterior aortic annulus (Fig. 1) .
Results
Qualitative examination of normalized two-dimensional displacement-versus-time plots in G+LVH-patients revealed subtle systolic anterior motion (SAM) of the intertrigonal mitral annulus and reduced longitudinal excursion compared to controls. Statistically significant differences were present for ROI 1 (P = 0.005), ROI 2 (P = 0.01) and ROI 4 (P < 0.0001, Fig. 1 ). In G+LVH+ patients, displacement-versus-time plots for all 4 ROIs differed significantly from those of controls resulting from a combination of SAM, diminished longitudinal excursion and blunted end-diastolic motion (Fig. 2) : ROI 1 (P = 0.02), ROI 2 (P = 0.007), ROI 3 (P < 0.0001) and ROI 4 (P < 0.0001).
Conclusions
The AMVL is longer in preclinical HCM, but in addition, there are more widespread abnormalities of the aorto-mitral apparatus motion, including SAM of the mitral annulus before the development of LVH or LA enlargement. These data have the potential to improve our understanding of early phenotype development and LVOTO-predisposition in HCM. 
